Abstract
Background
Marfan syndrome is associated with morbidity and mortality due to aortic dilatation and dissection. Preventive aortic root replacement has been the standard treatment in Marfan syndrome patients with aortic dilatation. In this study, we present aortic event data from a nationwide Marfan syndrome cohort.
Method
The nationwide cohort of Danish Marfan syndrome patients was established from the Danish National Patient Registry and the Cause of Death Register, where we retrieved information about aortic surgery and dissections. We associated aortic events with age, sex, and Marfan syndrome diagnosis prior or after the first aortic event.
Results
From the total cohort of 412 patients, 150 (36.4 %) had an aortic event. Fifty percent were event free at age 49.6. Eighty patients (53.3 %) had prophylactic surgery and seventy patients (46.7 %) a dissection. The yearly event rate was 0.02 events/year/patient in the period 1994–2014. Male patients had a significant higher risk of an aortic event at a younger age with a hazard ratio of 1.75 (CI 1.26–2.42, p = 0.001) compared with women. Fifty-three patients (12.9 %) were diagnosed with MFS after their first aortic event which primarily was aortic dissection [n = 44 (83.0 %)].
Conclusion
More than a third of MFS patients experienced an aortic event and male patients had significantly more aortic events than females. More than half of the total number of dissections was in patients undiagnosed with MFS at the time of their event. This emphasizes that diagnosing MFS is lifesaving and improves mortality risk by reducing the risk of aorta dissection.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- CPR:
-
Danish Central Personal Register
- CDR:
-
The Cause of death Register
- DNPR:
-
The Danish National Patient Register
- FBN1:
-
Fibrillin-1 gene
- Ghent-I:
-
First revised Ghent nosology [31]
- Ghent-II:
-
Second revised Ghent nosology [14]
- ICD:
-
International classification of disease
- MFS:
-
Marfan syndrome
- RR:
-
Relative risk
References
Murdoch JL, Walker BA, Halpern BL et al (1972) Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 286(15):804–808
Schaeffer BN, Rybczynski M, Sheikhzadeh S et al (2015) Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome. Clin Res Cardiol 104(12):1054–1063
Benedetto U, Melina G, Takkenberg JJ et al (2011) Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis. Heart 97(12):955–958
Erbel R, Aboyans V, Boileau C et al (2014) 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35(41):2873–2926
Treasure T, Takkenberg JJ, Pepper J (2014) Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms. Heart 100(20):1571–1576
David TE, David CM, Manlhiot C et al (2015) Outcomes of aortic valve-sparing operations in Marfan syndrome. J Am Coll Cardiol 66(13):1445–1453
Price J, Magruder JT, Young A et al (2015) Long-term outcomes of aortic root operations for Marfan syndrome: a comparison of Bentall versus aortic valve-sparing procedures. J Thorac Cardiovasc Surg 15:10
Kunihara T, Aicher D, Asano M et al (2014) Risk factors for prophylactic proximal aortic replacement in the current era. Clin Res Cardiol 103(6):431–440
Koene BM, Soliman Hamad MA, Bouma W et al (2014) Can postoperative mean transprosthetic pressure gradient predict survival after aortic valve replacement? Clin Res Cardiol 103(2):133–140
den Hartog AW, Franken R, Zwinderman AH et al (2015) The risk for type B aortic dissection in Marfan syndrome. J Am Coll Cardiol 65(3):246–254
Rylski B, Bavaria JE, Beyersdorf F et al (2014) Type A aortic dissection in Marfan syndrome: extent of initial surgery determines long-term outcome. Circulation 129(13):1381–1386
Bachet J, Goudot B, Dreyfus G et al (2000) Surgery of acute type A dissection: what have we learned during the past 25 years? Z Kardiol 89(Suppl 7):47–54
Jondeau G, Detaint D, Tubach F et al (2012) Aortic event rate in the Marfan population: a cohort study. Circulation 125(2):226–232
Loeys BL, Dietz HC, Braverman AC et al (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476–485
Groth KA, Hove H, Kyhl K et al (2015) Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis 2(10):153. doi:10.1186/s13023-015-0369-8.:153-0369
Schmidt M, Schmidt SA, Sandegaard JL et al (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 17(7):449–490. doi:10.2147/CLEP.S91125.eCollection@2015.:449-90
Helweg-Larsen K (2011) The Danish Register of causes of death. Scand J Public Health 39(7 Suppl):26–29
Mueller GC, Stark V, Steiner K et al (2013) Impact of age and gender on cardiac pathology in children and adolescents with Marfan syndrome. Pediatr Cardiol 34(4):991–998
Meijboom LJ, Timmermans J, Zwinderman AH et al (2005) Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol 96(10):1441–1444
Wanga S, Silversides C, Dore A et al (2016) Pregnancy and thoracic aortic disease: managing the risks. Can J Cardiol 32(1):78–85
Vedsted P (2007) Gender differences in the use of health care system. Ugeskr Laeger 169(25):2403–2408
Lo RC, Schermerhorn ML (2016) Abdominal aortic aneurysms in women. J Vasc Surg 63(3):839–844
Wu XF, Zhang J, Paskauskas S et al (2009) The role of estrogen in the formation of experimental abdominal aortic aneurysm. Am J Surg 197(1):49–54
Shores J, Berger KR, Murphy EA et al (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 330(19):1335–1341
Habashi JP, Judge DP, Holm TM et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770):117–121
Milleron O, Arnoult F, Ropers J et al (2015) Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J 36(32):2160–2166
Doenst T, Struning C, Moschovas A et al (2015) Cardiac surgery 2014 reviewed. Clin Res Cardiol 104(12):1006–1020
Groth KA, Gaustadnes M, Thorsen K et al (2016) Difficulties in diagnosing Marfan syndrome using current FBN1 databases. Genet Med 18(1):98–102
von Kodolitsch Y, De BJ, Schuler H et al (2015) Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Appl Clin Genet 16(8):137–155. doi:10.2147/TACG.S60472.eCollection@2015.:137-55
Beighton P, de Paepe A, Danks D et al (1988) International nosology of heritable disorders of connective tissue, Berlin, 1986. Am J Med Genet 29(3):581–594
De Paepe A, Devereux RB, Dietz HC et al (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62(4):417–426
Acknowledgments
This study is supported by the Department of Clinical Medicine, Aarhus University Hospital and Aarhus University and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the Scientific Ethical Committee of Region Midtjylland and the Danish Data Protection Agency.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Groth, K.A., Stochholm, K., Hove, H. et al. Aortic events in a nationwide Marfan syndrome cohort. Clin Res Cardiol 106, 105–112 (2017). https://doi.org/10.1007/s00392-016-1028-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-016-1028-3